Latest Breaking News On - Prnewswire armata pharmaceuticals inc - Page 1 : comparemela.com

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update

Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaireDeborah birxPierre kymeWarfighter medical research programPharmaceuticals incUs department of defenseArmata pharmaceuticals incTechnology enterprise consortiumLifesci advisorsDefense health agencyDepartment of defensePrnewswire armata pharmaceuticals incRecent developmentsClinical studyNorth american cystic fibrosis conference

Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P a Clinical Study at the North American Cystic Fibrosis Conference

Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P a Clinical Study at the North American Cystic Fibrosis Conference
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesPierre kymeLucasr hoffmanJoyce allaireCompany phaseJohns hopkins universityArmata pharmaceuticals incPhoenix convention centerLifesci advisorsArmata pharmaceuticals announces presentation of topline dataPrnewswire armata pharmaceuticals incPharmaceuticals announces presentationTopline dataNorth american cystic fibrosisNorth american cystic fibrosis conferenceChanging face

Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a diSArm Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus

Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a diSArm Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaireMina pastagiaPierre kymeDeborah birxDefense health agencyNaval medical researchData review committeeDepartment of defenseArmata pharmaceuticals incLifesci advisorsUs department of defenseTechnology enterprise consortiumWarfighter medical research programPrnewswire armata pharmaceuticals incChief executive officer

Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics.

United statesNew yorkPierre kymeDeborah birxJoyce allaireArmata pharmaceuticals incLifesci advisorsPrnewswire armata pharmaceuticals incChief executive officerCantor global healthcare conferenceArmata pharmaceuticalsSci advisors

Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update

/PRNewswire/ Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific.

United statesFrance generalPierre kymeDeborah birxDeborahl birxJoyce allairePrnewswire armata pharmaceuticals incArmata pharmaceuticals incDefense health agencyTechnology enterprise consortiumWarfighter medical research programUs department of defenseLifesci advisorsRecent developmentsInnoviva boardChief executive